Collaborative Research Accelerator Grants fosters an ecosystem of multiple diverse research teams, at all career stages, to address critical questions through a connected suite of research activity at the pace and scale that reflects the urgency of achieving our vision of Zero Deaths from breast cancer.

The strategic intent of the Collaborative Research Accelerator (CRA) grant scheme is to provide significant and recurrent funding for large-scale collaborative research activity. Funding aims to bring together the multidisciplinary skills and expertise of a collaborative ecosystem of researchers and research teams working together to address an intractable question with a clear line of sight to Zero Deaths from breast cancer.

The CRA grant scheme aims to enable visionary, transformative research at a scale and pace that cannot be achieved through singular, short-term research granting efforts. By encouraging crossinstitutional collaboration, reducing duplication of effort and leveraging co-funding, NBCF aims to amplify the reach and impact of the research - accelerating discoveries that reduce mortality and bring us closer to a future where no life is lost to breast cancer.

Applicants must demonstrate:

• Alignment of research question to one or more NBCF Pink Horizon research objective(s): Prevent, Detect, Stop or Treat.
• Lead Institution must be an Australian Administering Institution with an ABN committed to sub-contracting other collaborating institutions.
• Principal Investigator must be an Australian citizen / permanent resident or have the appropriate working visa valid for the duration of the grant and be affiliated with / employed by an Australian Administering Institution.
• Proposal must include at least two collaborating research institutions, including more than one Australian institution.
• Total grant value is equal to or less than AUD$25,000,000 over 5 years.
• Application must include a commitment to provide at least 20% in co-funding, comprising a minimum 10% cash contribution. The remaining balance can be in-kind support or further cash contributions. Applicants must provide details of their co-funding commitment, specifying both the total amount and the proportions of cash and in-kind contributions.
• Only one CRA can be submitted by a Principal Investigator in any CRA grant round.
• A Principal Investigator can only hold one active CRA grant at any point in time.
• Active involvement of people with a lived experience of breast cancer appropriate to the type of research (including a minimum of two named consumers).

• Email: research@nbcf.org.au